Mysinger Michael, based in California, United States, is currently a Principal Scientist at Atomwise, bringing experience from previous roles at SeaChange Pharmaceuticals, Inc, ConfometRx, Inc, University of California, San Francisco and Arqule. Mysinger Michael holds a 2005 - 2011 Ph.D. in Drug Development Sciences @ University of California, San Francisco. With a robust skill set that includes Docking, Virtual Screening, Cheminformatics, ADME, Chemistry and more, Mysinger Michael contributes valuable insights to the industry. Mysinger Michael has 3 emails on RocketReach.